Leave your feedback Share Copy URL https://ar-c.org/video/Dr5FAvffwuL.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter Andy Kim Discusses Possibility Of Adopting E.U. Drug Regulation Practices In The U.S. [bQ8pxVs19wp] Health Updated on August 07, 2026 EDT — Published on August 07, 2026 EDT At a Senate Aging Committee hearing on Wednesday, Sen. Andy Kim (D-NJ) asked a health policy researcher about a pharmaceutical vetting process practiced in the E.U. Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more: Stay Connected Forbes on Facebook: Forbes Video on Twitter: Forbes Video on Instagram: More From Forbes: TTc13IsSA88 OTv651EQdTM XSrpK0xvJT0 nmpAgOuHo7G S8A7Kx4DNfS 3cFi5FGKcxm
At a Senate Aging Committee hearing on Wednesday, Sen. Andy Kim (D-NJ) asked a health policy researcher about a pharmaceutical vetting process practiced in the E.U. Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more: Stay Connected Forbes on Facebook: Forbes Video on Twitter: Forbes Video on Instagram: More From Forbes: TTc13IsSA88 OTv651EQdTM XSrpK0xvJT0 nmpAgOuHo7G S8A7Kx4DNfS 3cFi5FGKcxm